Physician profile
Raymond Brig
NPI 1588664627
$4,684.27
in general payments reported to CMS, 2019-2025
33 companies · none reported in 2025
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $4,233 · 2020: $439 · 2021: $11.92.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $1,885.91 | 2019 | |
| Genentech USA, INC. | $392.32 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $361.54 | 2019-2020 | |
| Amgen INC. | $329.09 | 2019-2020 | |
| Celgene Corporation | $162.54 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $161.69 | 2019-2020 | |
| Lilly USA, LLC | $154.82 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $138.82 | 2019-2020 | |
| Pfizer INC. | $111.04 | 2019-2023 | |
| Asd Specialty Healthcare, LLC | $103.10 | 2019 | |
| Seagen INC. | $96.50 | 2019-2020 | |
| Puma Biotechnology, INC. | $94.77 | 2019-2020 | |
| Daiichi Sankyo INC. | $84.37 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $84.01 | 2019-2020 | |
| Eisai INC. | $70.36 | 2019 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elekta, INC. | $69.88 | 2019 | |
| Helsinn Therapeutics (U.S.), INC. | $48.90 | 2019 | |
| Mylan Institutional INC. | $44.95 | 2019-2020 | |
| Ipsen Biopharmaceuticals, INC | $34.29 | 2019-2020 | |
| Janssen Biotech, INC. | $30.01 | 2019-2020 | |
| Gilead Sciences, INC. | $28.71 | 2019-2021 | |
| Heron Therapeutics, INC. | $27.96 | 2019 | |
| Incyte Corporation | $27.80 | 2019 | |
| Zyla Life Sciences, INC. | $26.12 | 2019 | |
| Emd Serono, INC. | $24.86 | 2019-2020 | |
| Rigel Pharmaceuticals, INC. | $18.97 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.58 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $16.45 | 2019 | |
| Fortovia Therapeutics, INC. | $13.33 | 2019 | |
| Array Biopharma INC | $12.62 | 2020 | |
| Taiho Oncology, INC. | $10.96 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Research and ownership
$67,715.17 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raymond Brig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.